Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Moore

Showing results (41-50 of 354) with videos related to

Pageof 36
Sort By:
Therapie|July 10, 2016
Integrity of Scientific Data: Transparency of Clinical Trial DataNicholas Moore, Yves Juillet, Pierre-Henri Bertoye, et al.
Journal of Hepatology|May 20, 2014
New oral anticoagulants (NOAC) and liver injuryNicholas Moore, Patrick Blin, Sinem-Ezgi Gulmez
Therapie|September 7, 2007
Integrity of scientific data: transparency of clinical trial dataNicholas Moore, Yves Juillet, Pierre-Henri Bertoye, et al.
Therapie|July 10, 2016
[Not Available]Nicholas Moore, Yves Juillet, Pierre-Henri Bertoye, et al.
Emergency Medicine Australasia : EMA|October 14, 2020
Lost bed capacity in emergency departments: A descriptive analysis and data visualisation explorationPaul M Middleton, Nicholas Moore, Shiquan Ren
Lancet (London, England)|October 11, 2018
Inhaled triple therapy in chronic obstructive pulmonary diseaseMathieu Molimard, Pierre Oliver Girodet, Nicholas Moore
Idcases|May 19, 2023
When dyspnea is a Hickam's DictumAnnette Abraham, Nicholas Moore, Sarah E Sansom
Therapie|November 24, 2004
Uighur traditional medicine syndrome of Abnormal Savda in men is associated with oxidative stress, which can be improved by Munziq and Mushil of Abnormal SavdaHalmurat Upur, Abdiryim Yusup, Anwar Umar, et al.
Fundamental & Clinical Pharmacology|August 18, 2004
Protective effects of Munziq and Mushil of abnormal Savda to mitochondrial oxidative damageAbdiryim Yusup, Halmurat Upur, Anwar Umar, et al.
Current Medical Research and Opinion|October 2, 2012
A review of the pharmacokinetic profile of transmucosal fentanyl formulationsNicholas Moore, Mona Darwish, Xavier Amores, et al.
Pageof 36

Showing results (41-50 of 354) with videos related to

Sort By:
Pageof 36
Therapie|July 10, 2016
Integrity of Scientific Data: Transparency of Clinical Trial DataNicholas Moore, Yves Juillet, Pierre-Henri Bertoye, et al.
Journal of Hepatology|May 20, 2014
New oral anticoagulants (NOAC) and liver injuryNicholas Moore, Patrick Blin, Sinem-Ezgi Gulmez
Therapie|September 7, 2007
Integrity of scientific data: transparency of clinical trial dataNicholas Moore, Yves Juillet, Pierre-Henri Bertoye, et al.
Therapie|July 10, 2016
[Not Available]Nicholas Moore, Yves Juillet, Pierre-Henri Bertoye, et al.
Emergency Medicine Australasia : EMA|October 14, 2020
Lost bed capacity in emergency departments: A descriptive analysis and data visualisation explorationPaul M Middleton, Nicholas Moore, Shiquan Ren
Lancet (London, England)|October 11, 2018
Inhaled triple therapy in chronic obstructive pulmonary diseaseMathieu Molimard, Pierre Oliver Girodet, Nicholas Moore
Idcases|May 19, 2023
When dyspnea is a Hickam's DictumAnnette Abraham, Nicholas Moore, Sarah E Sansom
Therapie|November 24, 2004
Uighur traditional medicine syndrome of Abnormal Savda in men is associated with oxidative stress, which can be improved by Munziq and Mushil of Abnormal SavdaHalmurat Upur, Abdiryim Yusup, Anwar Umar, et al.
Fundamental & Clinical Pharmacology|August 18, 2004
Protective effects of Munziq and Mushil of abnormal Savda to mitochondrial oxidative damageAbdiryim Yusup, Halmurat Upur, Anwar Umar, et al.
Current Medical Research and Opinion|October 2, 2012
A review of the pharmacokinetic profile of transmucosal fentanyl formulationsNicholas Moore, Mona Darwish, Xavier Amores, et al.
Pageof 36